Independence of HIF1a and androgen signaling pathways in prostate cancer
<br><strong>Background: </strong>Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for prostate cancer. Although initially effective, resistance to androgen targeted therapies develops followed by disease progression to castrate-resistant prostate canc...
Main Authors: | Tran, MGB, Bibby, BAS, Yang, L, Lo, F, Warren, AY, Shukla, D, Osborne, M, Hadfield, J, Carroll, T, Stark, R, Scott, H, Ramos-Montoya, A, Massie, C, Maxwell, P, West, CML, Mills, IG, Neal, DE |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2020
|
Similar Items
-
The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man
by: Sharma, N, et al.
Published: (2012) -
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.
by: Sharma, N, et al.
Published: (2013) -
The early effects of rapid androgen deprivation on human prostate cancer
by: Shaw, G, et al.
Published: (2015) -
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.
by: Asim, M, et al.
Published: (2017) -
Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.
by: Shaida, N, et al.
Published: (2008)